B Complex W C And B12 Inj 50 mg / 10 mL Liquid is a Health Canada–registered human drug (DIN 00549762) held by E L Stickley And Co Ltd., containing Pyridoxine Hydrochloride. Health Canada lists its status as Cancelled Post Market (status date 09 Sep 1996). Nexara Health has matched 207 registrations of Pyridoxine Hydrochloride across 14 other regulated markets.

Health Canada registration

Pyridoxine Hydrochloride registered in other markets

207 registrations of the same molecule in 14 national registries outside Canada (first 56 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Pyridoxine Hydrochloride worldwide →

Regulator price references for Pyridoxine Hydrochloride

Published list or reimbursement prices for Pyridoxine Hydrochloride presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is B Complex W C And B12 Inj (DIN 00549762) marketed in Canada?

No. Health Canada lists DIN 00549762 as Cancelled Post Market as of 09 Sep 1996.

Who holds the Canadian licence for this product?

E L Stickley And Co Ltd. is the company of record in the Health Canada Drug Product Database.

Is Pyridoxine Hydrochloride registered outside Canada?

Yes — Nexara Health has matched 207 registrations in 14 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 00549762, status date 1996-09-09; national medicine registries: ANMDMR nomenclator, BDA, DH Drug Office, EDE, EU national register, FDA NDC, Lyfjastofnun lyfjaverdskra, Medicines Authority, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, TITCK; price sources: EDE, Lyfjastofnun lyfjaverdskra, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 00549762, status date 1996-09-09; national medicine registries: ANMDMR nomenclator, BDA, DH Drug Office, EDE, EU national register, FDA NDC, Lyfjastofnun lyfjaverdskra, Medicines Authority, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, TITCK; price sources: EDE, Lyfjastofnun lyfjaverdskra, SFDA.

Health Canada Drug Product Database (DPD), DIN 00549762, status date 1996-09-09; national medicine registries: ANMDMR nomenclator, BDA, DH Drug Office, EDE, EU national register, FDA NDC, Lyfjastofnun lyfjaverdskra, Medicines Authority, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, TITCK; price sources: EDE, Lyfjastofnun lyfjaverdskra, SFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.